Regular NSAID use may improve survival in head and neck cancer
A subset of patients with head and neck cancer (HNC) who regularly used aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) for more than 6 months showed longer disease-specific survival and overall survival than nonregular NSAID [more]